Genome-scale sequencing now allows us to generate massive amounts of genetic variant data that facilitates the discovery of new disease-associated genes

Yet for many disorders we still only understand a fraction of the genes that (when mutated) cause disease.  Our lab studies individuals and families with likely hereditary cancer susceptibility in order to discover new candidate genes for monogenic forms of hereditary breast cancer, polyposis, and other cancer types.